Retatrutide 20mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Retatrutide is a tri-agonist research peptide examined for its relevance to metabolic signalling, receptor-modulation modelling and biochemical pathway interaction involving GLP, GIP and glucagon-related axes. This lyophilized 20 mg preparation supports controlled laboratory evaluation of purity, identity and mechanistic behaviour.   Peptide Overview Between 2018 and 2025 Retatrutide has attracted significant scientific attention due to its multi-receptor activity profile and its modelling potential in metabolic-regulation studies. Its stable profile supports reproducible in-vitro research into pathway-specific signalling and comparative metabolic-modelling analysis.   Historical Background and Scientific Context Research into metabolic-agonist peptides expanded rapidly from 2020 onward as laboratories investigated multi-pathway receptor agonists for their biochemical behaviour and intracellular signalling patterns. Retatrutide became a reference compound for studies exploring receptor synergy, metabolic turnover and energy-regulatory pathways.   Mechanistic Focus in Research

• Modelling of GLP, GIP and glucagon-related receptor pathways
• Biochemical analysis of metabolic-turnover mechanisms
• In-vitro receptor-synergy and interaction studies
• Comparative analysis with related metabolic-agonist peptides
• Controlled multi-pathway modelling experiments

  Analytical Verification (COA) Independent Liquilabs analysis confirms full analytical validation for Batch GF082025026. Key results include:

• Assay Content: 19.90 mg
• Identification – Retention Time: 0.99
• Identification – Spectrum: 995
• Purity: above 99.8 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury vanadium

Values confirmed using validated chromatographic spectroscopic and microbiological methods ensuring full traceability.   Research Applications

• Metabolic-signalling and receptor-modulation modelling
• Pathway-interaction studies involving GLP GIP and glucagon axes
• Comparative metabolic-regulation analysis
• In-vitro biochemical modelling
• Multi-pathway mechanistic receptor evaluation

  Grail Formula Quality Every Grail Formula research peptide undergoes independent laboratory verification for purity identity structural integrity and microbial safety. All batches are validated for reproducibility and stability to ensure consistent scientific outcomes.   When You Choose Grail Formula… Researchers receive fully documented peptides with batch-number traceability sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside Europe only the peptide vial is supplied.   For research use only – not for human or veterinary use.

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF082025026 – Published August 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.